Therapy based on Tech, Amyl Therapeutics Closes €18.3 Million
Funds will be used to advance amyloid fibrils specific ClariTY technology platform as a potential best-in-class therapy for patients with Amyloidosis Amyl Therapeutics (‘Amyl’), a...
Category : Clinical Intelligence/Clinical Efficiency
Iksuda Therapeutics Closes $47 Million Financing Round
Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug conjugates, targeting tumours with high unmet need Investment round led by...
Ajax Therapeutics Raises $40 Million
Financing led by EcoR1 Capital with additional new investor, Boxer Capital Strategic collaboration with co-founder, Schrödinger, Inc., to develop pipeline of selectively targeted therapeutics Founding...
BostonGene’s Acceptance of Abstracts to 2021 ASCO Annual Meeting
BostonGene Corporation, a biomedical software company focused on defining optimal, precision medicine-based therapies for cancer patients, today announced that two abstracts have been accepted for...
Spaulding Clinical Expands Offerings for Later-Stage Clinical Trials
Biometrics, Data Management, Medical Writing Through Stage III Spaulding Clinical, a full-service Phase I clinical service provider, today announced expanded services for clinical trial Phases...
NiKang Therapeutics Announces Completion of $200 Million Series C
Bing Yao, Ph.D., former chief executive officer and chairman of Viela Bio, and Ting Jia, Ph.D., founder, and chief investment officer of Octagon Capital Advisors...
Clinical Intelligence Leader Inteliquet™ Highlights RWD Analysis
Real World Data Utilizing Patient Matching Technology Suggests the Same Treatment Regimen Delivered in Different Sequences Results in Different Outcomes Inteliquet, highlighted today Real World...
Ciitizen and RARE-X Collaborate to Improve Clinical Efficiency
Partnership supports the long tail of rare diseases and breaking down data silos to accelerate treatments A collaboration between Ciitizen, a healthcare technology company that helps...
Clinical Intelligence Company Caribou Biosciences Adds New Member
Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that it has expanded its scientific advisory board (SAB) with the appointment of...
Healthcare Tech Report Recognizes Wolters Kluwer’s Karen Kobelski
Wolters Kluwer, Health, a leading global provider of trusted clinical technology and evidence-based solutions, today announced that Karen Kobelski, Vice President and General Manager for Clinical...